Skip to main content
Year archive

Raphas Co., Ltd. — 2026 filings

All 19 regulatory filings released by Raphas Co., Ltd. (214260) in 2026, sourced directly from the official regulator.

19 Filings
2026 Period
2026 filings (19)
Filing Released Lang
[기재정정]투자판단관련주요경영사항(임상시험계획승인신청) (알레르기비염 면역치료제 DF19001의 임상 2b/3상 임상시험계획(IND) 승인 신청)
Regulatory Filings
2026-05-28 Korean
투자판단관련주요경영사항(임상시험계획승인신청) (알레르기비염 면역치료제 DF19001의 임상 2b/3상 임상시험계획(IND) 승인 신청)
Regulatory Filings
2026-05-22 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Q1 2026
2026-05-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2026-05-12 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2026-05-12 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2026-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2026-03-30 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2026-03-23 Korean
감사보고서제출
Audit Report / Information FY 2025
2026-03-20 Korean
사업보고서 (2025.12)
Audit Report / Information FY 2025
2026-03-20 Korean
[기재정정]주주총회소집공고
AGM Information
2026-03-20 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2026-03-11 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2026-03-10 Korean
주주총회집중일개최사유신고
AGM Information
2026-03-10 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2026-03-10 Korean
[기재정정]주주총회소집결의
Proxy Solicitation & Information Statement
2026-03-10 Korean
주주총회소집결의
Proxy Solicitation & Information Statement
2026-02-27 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2026-02-27 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update
2026-01-27 Korean